Speaking at GITEX Global, Albarah Elkhani, Senior Vice President Operations, M42 said, “At M42, we deliver quality healthcare for the community through technology and AI-enabled services.”
“Our aim is to support the reduction of healthcare expenses which is extremely imbalanced in line with the GDP. This drives the need for a sustainable healthcare solution,” he explains.
He emphasizes how AI can contribute to cost reduction and drive better outcomes: “AI enables personalized care, reducing the burden of disease and shift toward predictive, preventive and precision medicine.”
Highlighting M42’s flagship LLM model, he says, “Med42, a large language model, that allows the integration of data sets for insights. We collate a significant amount of data at M42 that facilitate a personalized patient journey through our population genome program and personalized medicine approach by integrating the data sets and pulling insights using AI advanced tools.”
On M42’s reach, he notes, “We work across Abu Dhabi, the broader region and globally.” He also explains AI’s role in clinical care: “AI helps us analyze petabytes of data — tasks that are humanly impractical —making insights accessible and proactive.”
-ENDS-
About M42
M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.
M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.
The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.
